Dr. Sundaresan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yawkey 7b
Boston, MA 02114Phone+1 617-632-3779
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
University of California (San Francisco)Residency, Internal Medicine, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2026
MA State Medical License 2011 - 2018
Publications & Presentations
PubMed
- 385 citationsA microfluidic device for label-free, physical capture of circulating tumor cell clustersA. Fatih Sarioglu, Nicola Aceto, Nikola Kojic, Maria C. Donaldson, Mahnaz Zeinali
Nature Methods. 2015-07-01 - 288 citationsDetection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K. Sundaresan, Lecia V. Sequist, John V. Heymach, Gregory J. Riely, Pasi A. Jänne
Clinical Cancer Research. 2016-03-01 - 444 citationsExpression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation.Benjamin Purow, Raqeeb M. Haque, Martha Noel, Qin Su, Michael J. Burdick
Cancer Research. 2005-03-15
Press Mentions
Blood Test May One Day Predict Breast Cancer RelapseAugust 26th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
